Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oncology Patients Receiving Chemotherapy”

804 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 804 results

Not applicableStudy completedNCT01716559
What this trial is testing

An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy

Who this might be right for
Anemia
Hoffmann-La Roche 160
Post-approval studies (Phase 4)WithdrawnNCT05183139
What this trial is testing

In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)Ended earlyNCT02392377
What this trial is testing

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Stage IB Esophageal AdenocarcinomaStage IIA Esophageal AdenocarcinomaStage IIB Esophageal Adenocarcinoma+3 more
Case Comprehensive Cancer Center 1
Large-scale testing (Phase 3)Ended earlyNCT04503668
What this trial is testing

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Who this might be right for
Gynecologic Cancer
University of Michigan Rogel Cancer Center 62
Not applicableActive Not RecruitingNCT05985551
What this trial is testing

Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment

Who this might be right for
Breast CancerChemotherapy EffectSentinel Lymph Node
Uppsala University 114
Large-scale testing (Phase 3)Study completedNCT03410693
What this trial is testing

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional Cell
Bayer 175
Large-scale testing (Phase 3)Not Yet RecruitingNCT05300945
What this trial is testing

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

Who this might be right for
Gastric CancerPeritoneal Metastases
Zhixin Cao 200
Large-scale testing (Phase 3)Ended earlyNCT00720512
What this trial is testing

Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 184
Large-scale testing (Phase 3)Study completedNCT03362177
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 165
Early research (Phase 1)Study completedNCT05465681
What this trial is testing

Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Who this might be right for
Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
Fujian Shengdi Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00082303
What this trial is testing

Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma, Non-Hodgkin
National Center for Complementary and Integrative Health (NCCIH) 60
Testing effectiveness (Phase 2)Ended earlyNCT02113553
What this trial is testing

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Who this might be right for
Breast Cancer
Armando Santoro, MD 45
Testing effectiveness (Phase 2)Study completedNCT04508400
What this trial is testing

Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients

Who this might be right for
Pediatric Cancer
Sun Yat-sen University 108
Very early researchStudy completedNCT01894451
What this trial is testing

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Who this might be right for
Inflammatory Breast Carcinoma
Dana-Farber Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Not applicableUnknownNCT04096846
What this trial is testing

Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate Chemotherapy

Who this might be right for
Acute Lymphoblastic Leukemia
Assiut University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Post-approval studies (Phase 4)Study completedNCT01394991
What this trial is testing

A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia

Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 504
Not applicableStudy completedNCT07328633
What this trial is testing

Prehabilitation Plus ERAS in Gastric Cancer Surgery

Who this might be right for
Gastric Cancer (GC)
The Affiliated Hospital of Qingdao University 136
Large-scale testing (Phase 3)Looking for participantsNCT07633236
What this trial is testing

Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy

Who this might be right for
Oncology Patients Receiving ChemotherapyCachexia-Anorexia SyndromeOncology
Blokhin's Russian Cancer Research Center 100
Next Page